Open AccessCytokine storm after heart transplantation in COVID‐19‐related haemophagocytic lymphohistiocytosis (HLH)
Author(s) -
Mahdavi Mohammad,
Hejri Golnar Mortaz,
Pouraliakbar Hamidreza,
Shahzadi Hossein,
Hesami Mahshid,
Houshmand Golnaz
Publication year - 2022
Publication title -
esc heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.787
H-Index - 25
ISSN - 2055-5822
DOI - 10.1002/ehf2.13728
Subject(s) - medicine , cytokine storm , ards , hemophagocytic lymphohistiocytosis , inflammation , macrophage activation syndrome , disseminated intravascular coagulation , heart transplantation , immunology , heart failure , sepsis , pathology , lung , covid-19 , disease , arthritis , infectious disease (medical specialty)
While severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection primarily causes inflammation in the respiratory system, there is growing evidence of extrapulmonary tissue damage mediated by the host innate immune system in children and adults. A cytokine storm can manifest as a viral‐induced haemophagocytic lymphohistiocytosis (HLH). Here, we present a previously healthy 8‐year‐old boy with newly diagnosed cardiac injury and COVID‐19‐related HLH syndrome with haemophagocytosis in bone marrow biopsy. After remission of inflammation, the patient underwent a heart transplant due to persistent cardiac failure. The histology of the explanted heart showed only a focal subtle subendocardial inflammation. Three days after transplant, he developed progressive acute respiratory distress syndrome (ARDS) with the rise of inflammatory markers. He unfortunately died after 20 days because of disseminated intravascular coagulation (DIC). For the first time, we described a child with COVID‐19‐related HLH and severe cardiac failure, which had a poor prognosis despite a heart transplant.